Spruce Biosciences, Inc.
SPRB
$52.64
$2.875.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 60.57% | 521.77% | |||
| Gross Profit | -60.57% | -521.77% | |||
| SG&A Expenses | -1.43% | -11.69% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 37.75% | 274.59% | |||
| Operating Income | -37.75% | -274.59% | |||
| Income Before Tax | -32.31% | 16.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -32.31% | 16.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -32.31% | 16.25% | |||
| EBIT | -37.75% | -274.59% | |||
| EBITDA | -35.33% | -267.29% | |||
| EPS Basic | 25.33% | 20.78% | |||
| Normalized Basic EPS | 25.33% | -71.99% | |||
| EPS Diluted | 25.33% | 20.78% | |||
| Normalized Diluted EPS | 25.33% | -71.99% | |||
| Average Basic Shares Outstanding | 77.18% | 5.73% | |||
| Average Diluted Shares Outstanding | 77.18% | 5.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||